Windtree Therapeutics falls as chairman resigns
** Shares of Windtree Therapeutics Inc WINT.O down 21.5%
at $5.23 before the bell
** WINT says it received a letter from James Huang
announcing his decision to resign as co's board chairman,
effective immediately
** In his letter, Huang says WINT's securities have not
reflected their true value; says decided to resign to focus on
other business pursuits
** As of last close, WINT was down ~22% this year
(Reporting by Bhanvi Satija in Bengaluru)
((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study